These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1257774)

  • 21. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications.
    Hoebel BG; Hernandez L; Schwartz DH; Mark GP; Hunter GA
    Ann N Y Acad Sci; 1989; 575():171-91; discussion 192-3. PubMed ID: 2699187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter: Effects of 5,6-dihydroxytryptamine on the metabolism of 5-hydroxytryptamine in the central nervous system of the rat.
    Baldessarini RJ; Gerson S
    J Pharm Pharmacol; 1973 Aug; 25(8):647-8. PubMed ID: 4148434
    [No Abstract]   [Full Text] [Related]  

  • 24. Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions.
    Zigmond MJ; Stricker EM
    Science; 1973 Nov; 182(4113):717-20. PubMed ID: 4752211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Food intake and amphetamine anorexia after selective forebrain norepinephrine loss.
    Ahlskog JE
    Brain Res; 1974 Dec; 82(2):211-40. PubMed ID: 4374293
    [No Abstract]   [Full Text] [Related]  

  • 26. Serotonin and catecholamine concentrations in brain of rats injected intracerebrally with 5,6-dihydroxytryptamine.
    Costa E; LeFevre H; Meek J; Revuelta A; Spano F; Strada S; Daly J
    Brain Res; 1972 Sep; 44(1):304-8. PubMed ID: 5056985
    [No Abstract]   [Full Text] [Related]  

  • 27. Depletion of brain serotonin following intraventricular 5,7-dihydroxytryptamine fails to disrupt sleep in the rat.
    Ross CA; Trulson ME; Jacobs BL
    Brain Res; 1976 Sep; 114(3):517-23. PubMed ID: 953773
    [No Abstract]   [Full Text] [Related]  

  • 28. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Mueller RA
    J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain 5-hydroxytryptamine and cyclic AMP in morphine tolerance and dependence.
    Way EL; Ho IK; Loh HH
    Adv Biochem Psychopharmacol; 1974; 10():219-31. PubMed ID: 4152551
    [No Abstract]   [Full Text] [Related]  

  • 30. Alcohol intake in the rat after lowering brain 5-hydroxtryptamine content by electrolytic midbrain raphé lesions, 5, 6-dihydroxytryptamine or p-chlorophenylalanine.
    Kiianmaa K
    Med Biol; 1976 Jun; 54(3):203-9. PubMed ID: 133276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity, avoidance learning and regional 5-hydroxytryptamine following intra-brain stem 5,7-dihydroxytryptamine and electrolytic midbrain raphe lesions in the rat.
    Lorens SA; Guldberg HC; Hole K; Köhler C; Srebro B
    Brain Res; 1976 May; 108(1):97-113. PubMed ID: 1276894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense oligodeoxynucleotides against the MOR-1 clone alter weight and ingestive responses in rats.
    Leventhal L; Cole JL; Rossi GC; Pan YX; Pasternak GW; Bodnar RJ
    Brain Res; 1996 May; 719(1-2):78-84. PubMed ID: 8782866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intracerebroventricular injection of 5,6-dihydroxytryptamine and 6-hydroxydopamine on supra-ependymal nerves.
    Lorez HP; Richards JG
    Brain Res; 1976 Oct; 116(1):165-71. PubMed ID: 974766
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma corticosterone changes following alterations in brain norepinephrine and serotonin.
    McKinney WT; Prange AJ; Majchowicz E; Schlesinger K
    Dis Nerv Syst; 1971 May; 32(5):308-13. PubMed ID: 4397134
    [No Abstract]   [Full Text] [Related]  

  • 35. Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area.
    Klitenick MA; Wirtshafter D
    J Pharmacol Exp Ther; 1995 Apr; 273(1):327-36. PubMed ID: 7714785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical consequences of kainic acid injection into the lateral brain ventricle in rat.
    Kleinrok Z; Turski L
    Acta Biochim Pol; 1981; 28(2):111-22. PubMed ID: 6119862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of nicotine on feeding and body weight in rats: involvement of cocaine- and amphetamine-regulated transcript peptide.
    Dandekar MP; Nakhate KT; Kokare DM; Subhedar NK
    Behav Brain Res; 2011 May; 219(1):31-8. PubMed ID: 21147173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural and hormonal consequences of neonatal 5,7-dihydroxytryptamine may not be associated with serotonin depletion.
    Knuth ED; Etgen AM
    Brain Res Dev Brain Res; 2004 Jul; 151(1-2):203-8. PubMed ID: 15246707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of compounds structurally related to 5,6-dihydroxytryptamine on behavior and brain biogenic amines in the rat.
    Donelson AC; Manian AA; Maickel RP
    Res Commun Chem Pathol Pharmacol; 1982 Dec; 38(3):517-20. PubMed ID: 7163644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental alterations in 5-hydroxytryptamine concentration and turnover after treatment of neonatal rats with 5,7-dihydroxytryptamine.
    Mercugliano M; Nguyen H; Djali S; Lucki I
    Neurobiol Learn Mem; 1996 Mar; 65(2):163-76. PubMed ID: 8833105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.